38 -5 (79) 2025 - Rustamov M.K. - TREATMENT OF SEBORRHEIC DERMATITIS: CLINICAL AND REVIEW ANALYSIS

TREATMENT OF SEBORRHEIC DERMATITIS: CLINICAL AND REVIEW ANALYSIS

Rustamov M.K. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Resume

Seborrheic dermatitis, often known as SD, is a persistent and recurrent inflammatory skin illness that is characterized by the appearance of erythematous macules or plaques, with variable degrees of scaling and itching simultaneously. This condition usually occurs as an inflammatory response to Malassezia species and usually manifests on seborrheic areas such as the scalp, face, chest, back, axillae, and groin area. The goal of treatment for scleroderma is to eradicate the symptoms of the disease, alleviate the symptoms that are linked with it, such as pruritus, and sustain remission by the use of long-term administration of therapy. As a result of the fact that the primary pathogenetic pathways are inflammation and the multiplication of Malassezia, the most often utilized therapies are anti-inflammatory and anti-fungal medications that are applied topically. Lithium gluconate/succinate, coal tar, salicylic acid, selenium sulfide, sodium sulfacetamide, glycerin, benzoyl peroxide, aloe vera, mud treatment, phototherapy, and other therapies are also considered to be common treatments. It has also been claimed that alternative treatments, such as tea tree oil, Guassia amara, and Solanum chrysotrichum, have been implemented. In circumstances where topical treatment is unsuccessful or when the lesions are large, systemic medication is the sole treatment option. Therefore, in this extensive analysis, we have endeavored to provide relevant counsel for future situations that dermatologists may encounter. We have also provided a summary of the current information on the management of diabetes mellitus (DM)

Keywords: Malassezia, seborrheic dermatitis, skin barrier function

First page

186

Last page

190

For citation:Rustamov M.K. - TREATMENT OF SEBORRHEIC DERMATITIS: CLINICAL AND REVIEW ANALYSIS//New Day in Medicine 5(79)2025 186-190 https://newdayworldmedicine.com/en/new_day_medicine/5-79-2025

List of References

  1. Borda LJ, Wikramanayake TC. Seborrheic Dermatitis and Dandruff: A Comprehensive Review. J Clin Investig Dermatol. 2015;3(2).
  2. Schwartz JR, Messenger AG, Tosti A, Todd G, Hordinsky M, Hay RJ, et al. A comprehensive pathophysiology of dandruff and seborrheic dermatitis - towards a more precise definition of scalp health. Acta dermato-venereologica. 2013;93(2):131
  3. Dessinioti C, Katsambas A. Seborrheic dermatitis: etiology, risk factors, and treatments:facts and controversies. Clin Dermatol. 2013;31(4):343-51.
  4. Sampaio AL, Mameri AC, Vargas TJ, Ramos-e-Silva M, Nunes AP, Carneiro SC. Seborrheic dermatitis. An Bras Dermatol. 2011;86(6):1061-71; quiz 72-4.
  5. Bukvic Mokos Z, Kralj M, Basta-Juzbasic A, Lakos Jukic I. Seborrheic dermatitis: an update. Acta Dermatovenerol Croat. 2012;20(2):98-104.
  6. Buechner SA. Multicenter, double-blind, parallel group study investigating the non-inferiority of efficacy and safety of a 2% miconazole nitrate shampoo in comparison with a 2% ketoconazole shampoo in the treatment of seborrhoeic dermatitis of the scalp. J Dermatolog Treat. 2014;25(3):226-31.
  7. Azimi H, Golforoushan F, Jaberian M, Talghini S, Goldust M. Efficiency of terbinafine 1% cream in comparison with ketoconazole 2% cream and placebo in patients with facial seborrheic dermatitis. J Dermatolog Treat. 2013.
  8. Okokon EO, Verbeek JH, Ruotsalainen JH, Ojo OA, Bakhoya VN. Topical antifungals for seborrhoeic dermatitis. Cochrane Database Syst Rev. 2015(5):CD008138.
  9. Faergemann J. Seborrhoeic dermatitis and Pityrosporum orbiculare: treatment of seborrhoeic dermatitis of the scalp with miconazole-hydrocortisone (Daktacort), miconazole and hydrocortisone. Br J Dermatol. 1986;114(6):695-700.
  10. Attarzadeh Y, Asilian A, Shahmoradi Z, Adibi N. Comparing the efficacy of Emu oil with clotrimazole and hydrocortisone in the treatment of seborrheic dermatitis: A clinical trial. J Res Med Sci. 2013;18(6):477-81.

    file

    download